Purchase Order 75F40121P00531

The U.S. Food and Drug Administration (FDA) awarded a Firm Fixed Price Purchase Order contract worth $94,003.45 to Charles River Laboratories Cell Solutions, Inc. for the provision of human primary CD34+ hematopoietic stem and progenitor cells. This contract supports the FDA's Center for Biologics Evaluation and Research (CBER), Division of Cell and Gene Therapy (DCGT) in conducting critical path research to develop and promote technology for the regulation of cellular and genetic...

This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services' National Institutes of Health (NIH), to Stemcell Technologies Inc. for EASYSEP NEGATIVE HUMAN CD4 KITS. The $59,775.00 contract has a completion date of July 31, 2019 and was awarded on July 19, 2018 with no set-aside designation. Stemcell Technologies Inc. is a subsidiary of the Canadian company Stemcell Technologies, which...

The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $17,450.00 Firm Fixed Price purchase order contract to Stemcell Technologies Inc., a Canadian-owned for-profit organization, for the delivery of HUMAN CD8 KITS. The contract has a completion date of June 22, 2018 and does not have a set-aside designation. Stemcell Technologies Inc. is an active supplier of specialized biological materials, laboratory...

This federal contract award was made by the National Institutes of Health (NIH) to Stemcell Technologies Inc., a Canadian biotechnology company that specializes in cell culture media, cell separation systems, and other life sciences research products. The contract, which is a Blanket Purchase Agreement (BPA) with a ceiling value of $10,000,000, authorizes Stemcell Technologies Inc. to provide a comprehensive range of biological materials, blood and blood products, laboratory supplies, media, and...

This federal contract award to Stemcell Technologies Inc., a Canadian biotechnology company, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a sub-agency of the U.S. Department of Health and Human Services (HHS). The $24,536.00 firm fixed-price purchase order is for the provision of the AMBIS 1787964 QUOTE Q-921198 item, which is described as the "EASY STEP NEGATIVE HUMAN CD4 KIT". The award does not have a small business set-aside designation. Stemcell...

This is a cost-plus-fixed-fee definitive contract awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Platelet Biogenesis, Inc. The contract, valued at $4,998,785.00, requires the contractor to utilize its technology to differentiate human induced pluripotent stem cells into pre-megakaryocytes, which are then cryopreserved. The frozen pre-megakaryocytes will be thawed and further differentiated into mature megakaryocytes. This...

This is a federal contract award to Stemcell Technologies Inc., a Canadian biotechnology company, for the supply of an EasySep Negative Human CD4 Kit, catalog number 19052. The award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract has a ceiling value of $39,906.40 and is structured as a firm fixed price purchase order. The contract is...

The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services (HHS), awarded a $45,760.35 firm-fixed-price purchase order contract to Stemcell Technologies Inc. on January 31, 2017. The contract is for an "Immunomagnetic Cell Separator" and had a completion date of February 28, 2017. Stemcell Technologies Inc. is a Canadian biotechnology company that specializes in cell culture media, cell separation systems, and...

This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a Canadian biotechnology company. The $6,699 firm fixed-price contract is for the delivery of EasySep Negative Human CD4 Kits, which are specialized cell isolation products used to support biomedical research, particularly in areas like immunology and infectious disease investigations....

This firm fixed price purchase order was awarded by the Department of Defense Uniformed Services University of the Health Sciences to the Fred Hutchinson Cancer Research Center, a non-profit organization, on May 15, 2018. The contract is for the delivery of 20 vials of cryopreserved blood stem cells, with a potential value of $11,250.00 and a completion date of May 18, 2018. The work is to be performed in Seattle, WA. Fred Hutchinson Cancer Research Center has held other federal contracts and...